A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

Clinical trial NCT01272258 · WITHDRAWN

Trial details

NCT number

NCT01272258

Sponsor

CytoDyn, Inc.

Status

WITHDRAWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-12-01

Primary completion

2017-01-01

Enrollment

0

View on ClinicalTrials.gov